A Study of SHR2554 With Chemotherapy in Treatment-na ïve Patients With Peripheral T-cell Lymphoma

Conditions: Peripheral T-cell Lymphoma Interventions: Drug: SHR2554/CHOP; Drug: SHR2554/CHOEP Sponsors: Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials